445 related articles for article (PubMed ID: 32141531)
41. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA-17 promotes osteosarcoma cells proliferation and migration and inhibits apoptosis by regulating SASH1 expression.
Wu D; Zhang H; Ji F; Ding W
Pathol Res Pract; 2019 Jan; 215(1):115-120. PubMed ID: 30396754
[TBL] [Abstract][Full Text] [Related]
43. Knockdown of HCG18 Inhibits Cell Viability, Migration and Invasion in Pediatric Osteosarcoma by Targeting miR-188-5p/FOXC1 Axis.
Zhao Z; Chen J; Xia D
Mol Biotechnol; 2021 Sep; 63(9):807-817. PubMed ID: 34041718
[TBL] [Abstract][Full Text] [Related]
44. miR-210-5p promotes epithelial-mesenchymal transition by inhibiting PIK3R5 thereby activating oncogenic autophagy in osteosarcoma cells.
Liu W; Jiang D; Gong F; Huang Y; Luo Y; Rong Y; Wang J; Ge X; Ji C; Fan J; Cai W
Cell Death Dis; 2020 Feb; 11(2):93. PubMed ID: 32024814
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-31 inhibits osteosarcoma cell proliferation, migration and invasion by targeting PIK3C2A.
Chao LM; Sun W; Chen H; Liu BY; Li PF; Zhao DW
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7205-7213. PubMed ID: 30468462
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting Sirtuin 1.
Shi Y; Huang J; Zhou J; Liu Y; Fu X; Li Y; Yin G; Wen J
Oncol Rep; 2015 Jul; 34(1):399-406. PubMed ID: 25998694
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
Jia F; Zhang Z; Zhang X
J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892
[TBL] [Abstract][Full Text] [Related]
48. miR-624-5p promoted tumorigenesis and metastasis by suppressing hippo signaling through targeting PTPRB in osteosarcoma cells.
Luo Y; Liu W; Tang P; Jiang D; Gu C; Huang Y; Gong F; Rong Y; Qian D; Chen J; Zhou Z; Zhao S; Wang J; Xu T; Wei Y; Yin G; Fan J; Cai W
J Exp Clin Cancer Res; 2019 Dec; 38(1):488. PubMed ID: 31829261
[TBL] [Abstract][Full Text] [Related]
49. Circular RNA circ_0102049 promotes cell progression as ceRNA to target MDM2 via sponging miR-1304-5p in osteosarcoma.
Jin Y; Li L; Zhu T; Liu G
Pathol Res Pract; 2019 Dec; 215(12):152688. PubMed ID: 31727503
[TBL] [Abstract][Full Text] [Related]
50. miR-186-5p Functions as a Tumor Suppressor in Human Osteosarcoma by Targeting FOXK1.
Zhang Z; Zhang W; Mao J; Xu Z; Fan M
Cell Physiol Biochem; 2019; 52(3):553-564. PubMed ID: 30897321
[TBL] [Abstract][Full Text] [Related]
51. The expression and function of miRNA-106 in pediatric osteosarcoma.
Xu M; Zhang YY; Wang HF; Yang GS
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):715-722. PubMed ID: 28272712
[TBL] [Abstract][Full Text] [Related]
52. Knocking down miR-384 promotes growth and metastasis of osteosarcoma MG63 cells by targeting SLBP.
Wang Y; Huang H; Li Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1458-1465. PubMed ID: 31007083
[TBL] [Abstract][Full Text] [Related]
53. MiR-15 suppressed the progression of bladder cancer by targeting BMI1 oncogene via PI3K/AKT signaling pathway.
Zhang L; Wang CZ; Ma M; Shao GF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8813-8822. PubMed ID: 31696468
[TBL] [Abstract][Full Text] [Related]
54. Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.
Bao Y; Chen B; Wu Q; Hu K; Xi X; Zhu W; Zhong X; Chen J
Clin Exp Med; 2017 Feb; 17(1):51-58. PubMed ID: 26515813
[TBL] [Abstract][Full Text] [Related]
55. LncRNA MALAT1 Promotes Cancer Metastasis in Osteosarcoma via Activation of the PI3K-Akt Signaling Pathway.
Chen Y; Huang W; Sun W; Zheng B; Wang C; Luo Z; Wang J; Yan W
Cell Physiol Biochem; 2018; 51(3):1313-1326. PubMed ID: 30481748
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-22 targets FMNL2 to inhibit melanoma progression via the regulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
Shi L; Huo JW; Chen SS; Xue JX; Gao WY; Li XY; Song YH; Xu HT; Zhu XW; Chen K
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5332-5342. PubMed ID: 31298385
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway.
Zhu L; Chen Y; Liu J; Nie K; Xiao Y; Yu H
Cancer Biomark; 2020; 29(3):347-357. PubMed ID: 32716350
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA miR-331-3p suppresses osteosarcoma progression via the Bcl-2/Bax and Wnt/β-Catenin signaling pathways and the epithelial-mesenchymal transition by targeting N-acetylglucosaminyltransferase I (MGAT1).
Bi W; Yang M; Xing P; Huang T
Bioengineered; 2022 Jun; 13(6):14159-14174. PubMed ID: 35758024
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion.
Liu YJ; Li W; Chang F; Liu JN; Lin JX; Chen DX
Oncol Rep; 2018 Feb; 39(2):491-500. PubMed ID: 29251324
[TBL] [Abstract][Full Text] [Related]
60. The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression.
Shekhar R; Priyanka P; Kumar P; Ghosh T; Khan MM; Nagarajan P; Saxena S
J Biol Chem; 2019 Mar; 294(12):4381-4400. PubMed ID: 30679313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
